Suppr超能文献

非创伤性疾病损伤控制性策略研究:单中心观察性研究。

Study of damage control strategy for non-traumatic diseases: a single-center observational study.

机构信息

Department of Emergency and Critical Care Medicine, Kansai Medical University, Shinmachi 2-5-1, Hirakata, Osaka, 573-1010, Japan.

出版信息

Eur J Med Res. 2022 Oct 1;27(1):192. doi: 10.1186/s40001-022-00823-8.

Abstract

BACKGROUND

Damage control strategy (DCS) has been introduced not only for trauma but also for acute abdomen, but its indications and usefulness have not been clarified. We examined clinical characteristics of patients who underwent DCS and compared clinical characteristics and results with and without DCS in patients with septic shock.

METHODS

We targeted a series of endogenous abdominal diseases in Kansai Medical University Hospital from April 2013 to March 2019. Clinical characteristics of 26 patients who underwent DCS were examined. Then, clinical characteristics and results were compared between the DCS group (n = 26) and non-DCS group (n = 31) in 57 patients with septic shock during the same period.

RESULTS

All 26 patients who underwent DCS had septic shock, low mean arterial pressure (MAP) before the start of surgery, and required high-dose norepinephrine administration intraoperatively. Their discharge mortality rate was 12%. Among the patients with septic shock, the DCS group had a higher SOFA score (P = 0.008) and MAP was lower preoperatively, but it did not increase even with intraoperative administration of large amounts of fluid replacement and vasoconstrictor. There was no significant difference in 28-day mortality and discharge mortality between the two groups.

CONCLUSIONS

DCS may be useful in patients with severe septic shock.

摘要

背景

损伤控制策略(DCS)不仅用于创伤,也用于急性腹痛,但尚未明确其适应证和有效性。我们检查了接受 DCS 治疗的患者的临床特征,并比较了感染性休克患者中接受和未接受 DCS 治疗的患者的临床特征和结果。

方法

我们以 2013 年 4 月至 2019 年 3 月期间关西医科大学医院的一系列内源性腹部疾病为目标,检查了 26 例行 DCS 的患者的临床特征。然后,在同期 57 例感染性休克患者中,比较了 DCS 组(n=26)和非 DCS 组(n=31)的临床特征和结果。

结果

所有接受 DCS 的 26 例患者均患有感染性休克,手术开始前平均动脉压(MAP)较低,术中需要大剂量去甲肾上腺素给药。他们的出院死亡率为 12%。在感染性休克患者中,DCS 组的 SOFA 评分更高(P=0.008),术前 MAP 较低,但即使术中给予大量液体替代和血管收缩剂,MAP 也没有升高。两组的 28 天死亡率和出院死亡率无显著差异。

结论

DCS 可能对严重感染性休克患者有用。

相似文献

5
Effect of norepinephrine on the outcome of septic shock.去甲肾上腺素对感染性休克结局的影响。
Crit Care Med. 2000 Aug;28(8):2758-65. doi: 10.1097/00003246-200008000-00012.

本文引用的文献

10
Severe sepsis and septic shock.严重脓毒症和脓毒性休克。
N Engl J Med. 2013 Aug 29;369(9):840-51. doi: 10.1056/NEJMra1208623.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验